These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4268202)

  • 1. Monitoring antifibrinolytic therapy in subarachnoid hemorrhage.
    Smith RR; Upchurch JJ
    J Neurosurg; 1973 Mar; 38(3):339-44. PubMed ID: 4268202
    [No Abstract]   [Full Text] [Related]  

  • 2. Streptokinase clot lysis time in patients with ruptured intracranial aneurysms.
    Geronemus R; Herz DA; Shulman K
    J Neurosurg; 1974 Apr; 40(4):499-503. PubMed ID: 4814382
    [No Abstract]   [Full Text] [Related]  

  • 3. Fibrinolytic activity in blood and cerebrospinal fluid in subarachnoid hemorrhage from ruptured intracranial saccular aneurysm before and during EACA treatment.
    Filizzolo F; D'angelo V; Collice M; Ferrara M; Donati MB; Porta M
    Eur Neurol; 1978; 17(1):43-7. PubMed ID: 624294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Letter: Epsilon-aminocaproic acid.
    Shaw MD; Miller JD
    Lancet; 1974 Nov; 2(7891):1264. PubMed ID: 4139496
    [No Abstract]   [Full Text] [Related]  

  • 5. Antifibrinolytic activity during administration of epsilon-aminocaproic acid.
    Nibbelink DW
    Stroke; 1971; 2(6):555-8. PubMed ID: 5164583
    [No Abstract]   [Full Text] [Related]  

  • 6. Antifibrinolytic therapy for intracranial aneurysms.
    Mullan S; Dawley J
    J Neurosurg; 1968 Jan; 28(1):21-3. PubMed ID: 5639737
    [No Abstract]   [Full Text] [Related]  

  • 7. Biochemical changes after spontaneous subarachnoid haemorrhage. 3. Coagulation and lysis with special reference to recurrent haemorrhage.
    Uttley AH; Buckell M
    J Neurol Neurosurg Psychiatry; 1968 Dec; 31(6):621-7. PubMed ID: 5709849
    [No Abstract]   [Full Text] [Related]  

  • 8. Epsilon-aminocaproic acid and recurrent subarachnoid hemorrhage: a clinical trial.
    Shucart WA; Hussain SK; Cooper PR
    J Neurosurg; 1980 Jul; 53(1):28-31. PubMed ID: 7411206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifibrinolytics in the treatment of subarachnoid hemorrhages due to ruptured aneurysms.
    Schisano G
    J Neurosurg Sci; 1975; 19(1-2):79-80. PubMed ID: 1082929
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hemostatic processes in aneurysmal hemorrhages].
    Hindersin P; Heidrich R
    Psychiatr Neurol Med Psychol (Leipz); 1977 Mar; 29(3):129-44. PubMed ID: 877166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of antifibrinolytic substances in ruptured intracranial aneurysms.
    Norlén G; Thulin CA
    Neurochirurgia (Stuttg); 1969 May; 12(3):100-2. PubMed ID: 5790480
    [No Abstract]   [Full Text] [Related]  

  • 12. Antifibrinolytic therapy in subarachnoid hemorrhage caused by ruptured intracranial aneurysm.
    Ramirez-Lassepas M
    Neurology; 1981 Mar; 31(3):316-22. PubMed ID: 7010208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current status of intrathecal antifibrinolytic therapy with p-aminomethylbenzoic acid (PAMBA) in subarachnoid hemorrhages].
    Hindersin P; Endler S; Heidrich R; Lehmann W; Dietrich J
    Psychiatr Neurol Med Psychol (Leipz); 1985 Dec; 37(12):686-9. PubMed ID: 3879362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifibrinolytic therapy in ruptured intracranial aneurysm through repeated monitoring of fibrinolytic activity of blood.
    Watanabe H; Ito M; Chigasaki H; Ishii S
    Neurol Med Chir (Tokyo); 1976; 16(PT1):91-6. PubMed ID: 66644
    [No Abstract]   [Full Text] [Related]  

  • 15. Antifibrinolytic therapy in patients with aneurysmal subarachnoid hemorrhage. A report of the cooperative aneurysm study.
    Adams HP; Nibbelink DW; Torner JC; Sahs AL
    Arch Neurol; 1981 Jan; 38(1):25-9. PubMed ID: 7458720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The fibrinolytic activity of cerebrospinal fluid after subarachnoid hemorrhage.
    Steinmetz H; Grote E
    Neurol Res; 1983; 5(4):59-65. PubMed ID: 6149487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effectiveness of antifibrinolytic, edema-preventing and hypotensive agents in the prevention of recurrent bleeding from intracranial aneurysms].
    Bromowicz J; Bryniarska D; Koniar-Danilewicz H; Danilewicz B
    Neurol Neurochir Pol; 1979; 13(6):647-51. PubMed ID: 514441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status of antifibrinolytic therapy for treatment of patients with aneurysmal subarachnoid hemorrhage.
    Adams HP
    Stroke; 1982; 13(2):256-9. PubMed ID: 7039006
    [No Abstract]   [Full Text] [Related]  

  • 19. Fibrinolysis and subarachnoid haemorrhage. Inhibitory effect of tranexamic acid. A clinical study.
    Tovi D; Nilsson IM; Thulin CA
    Acta Neurol Scand; 1972; 48(4):393-402. PubMed ID: 5072650
    [No Abstract]   [Full Text] [Related]  

  • 20. Coagulation and fibrinolysis in blood and cerebrospinal fluid after aneurysmal subarachnoid haemorrhage: effect of tranexamic acid (AMCA).
    Fodstad H; Nilsson IM
    Acta Neurochir (Wien); 1981; 56(1-2):25-38. PubMed ID: 7195642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.